Division of Molecular Medicine, Cardiovascular Research Laboratories, Department of Anesthesiology, David Geffen School of Medicine at University of California Los Angeles, 650 Charles E. Young Drive, Los Angeles, CA 90095, USA.
J Mol Cell Cardiol. 2010 Jun;48(6):1060-70. doi: 10.1016/j.yjmcc.2009.11.020. Epub 2010 Jan 12.
We have recently shown that a novel endothelial mitogen netrin-1 potently stimulates nitric oxide (NO()) production via a DCC-ERK1/2 dependent mechanism. In view of the well-established cardioprotective role of NO(), the present study investigated whether netrin-1 is cardioprotective via NO() signaling in the heart. Netrin-1 receptor DCC was abundantly expressed in the C57BL/6J mouse hearts. Perfusion of heart with netrin-1 (100 ng/mL) using a Langendorff system significantly increased NO() production. Under ischemia/reperfusion (I/R), netrin-1 induced a substantial reduction in infarct size (21.8+/-4.9% from 42.5+/-3.6% in the controls), which was accompanied by an augmented production of NO(). Pre-perfusion with DCC-antibody, U0126 (MEK1/2 inhibitor), L-NAME or PTIO (NO() scavenger) attenuated protective effects of netrin-1 on infarct size and NO() production, indicating upstream roles of DCC and ERK1/2 in NO() production, as well as an essential role of NO() in cardioprotection. Netrin-1 induced reduction in infarct size was significantly attenuated in DCC+/- mice, confirming an intermediate role of DCC. In additional experiments we found netrin-1 increased ERK1/2 and eNOS(s1177) phosphorylation, and DCC protein expression, which was diminished by I/R. Furthermore, netrin-1-induced DCC upregulation was NO() and ERK1/2-dependent, implicating a feed-forward mechanism. DAF-AM staining revealed enhanced NO() production in both cardiac endothelial cells (ECs) and myocytes. In primarily isolated cardiomyocytes, netrin-1 also increased NO() production, DCC abundance and ERK1/2 phosphorylation. Of note, cardiac apoptosis was significantly attenuated by netrin-1, which was reversed by DCC-antibody, U0126, L-NAME or PTIO. In summary, our data clearly demonstrate that netrin-1 potently protects the heart from I/R injury by stimulating NO() production from cardiac ECs and myocytes. This potent effect is mediated by a DCC/ERK1/2/eNOS(s1177)/NO()/DCC feed-forward mechanism in both cell types.
我们最近发现一种新型的内皮细胞有丝分裂原 netrin-1 通过 DCC-ERK1/2 依赖机制强烈刺激一氧化氮 (NO()) 的产生。鉴于 NO() 的明确的心脏保护作用,本研究探讨了 netrin-1 是否通过心脏中的 NO()信号传递发挥心脏保护作用。在 C57BL/6J 小鼠心脏中,netrin-1 受体 DCC 大量表达。使用 Langendorff 系统用 netrin-1(100ng/mL)灌注心脏可显著增加 NO()的产生。在缺血/再灌注 (I/R) 期间,netrin-1 可使梗塞面积显著减少(从对照组的 42.5+/-3.6%减少到 21.8+/-4.9%),同时 NO()的产生增加。预灌注 DCC 抗体、U0126(MEK1/2 抑制剂)、L-NAME 或 PTIO(NO()清除剂)减弱了 netrin-1 对梗塞面积和 NO()产生的保护作用,表明 DCC 和 ERK1/2 在 NO()产生中的上游作用,以及 NO()在心脏保护中的重要作用。在 DCC+/- 小鼠中,netrin-1 诱导的梗塞面积减少明显减弱,证实了 DCC 的中间作用。在额外的实验中,我们发现 netrin-1 增加了 ERK1/2 和 eNOS(s1177)的磷酸化以及 DCC 蛋白表达,而 I/R 则减少了这些表达。此外,netrin-1 诱导的 DCC 上调依赖于 NO()和 ERK1/2,暗示了一种正反馈机制。DAF-AM 染色显示心脏内皮细胞 (ECs) 和心肌细胞中 NO()的产生增加。在原代分离的心肌细胞中,netrin-1 也增加了 NO()的产生、DCC 的丰度和 ERK1/2 的磷酸化。值得注意的是,netrin-1 显著减轻了心脏细胞凋亡,而 DCC 抗体、U0126、L-NAME 或 PTIO 则逆转了这种凋亡。总之,我们的数据清楚地表明,netrin-1 通过刺激心脏 ECs 和心肌细胞中 NO()的产生,有力地保护心脏免受 I/R 损伤。这种强烈的作用是通过两种细胞类型中的 DCC/ERK1/2/eNOS(s1177)/NO()/DCC 正反馈机制介导的。